Nifty

:

25195.80

Sensex

:

82570.91

113.50 (0.45%)
317.45 (0.39%)

Login

Nifty
Sensex

:
:

25195.80
82570.91

113.50 (0.45%)
317.45 (0.39%)

Syngene International Ltd.

Pharmaceuticals & Drugs - Global

Rating :

48/99

BSE: 539268 | NSE: SYNGENE

Watchlist

NSE BSE

655.35

15-Jul-2025

Open
High
Low
Previous Close

642.3
659.9
642.2
636.30

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1969741
1289625641
960.6
599.55

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

26,410.66
52.06
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

25,743.36
0.19%
5.56

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.79
10.77
4.49

EBITDA CAGR (%)

10 Years
5 Years
3 Years

9.20
9.79
2.24

PAT CAGR (%)

10 Years
5 Years
3 Years

6.87
4.15
2.23

P:E (Median)

8 Years
5 Years
3 Years

56.30
58.20
58.18

P:BV (Average)

8 Years
5 Years
3 Years

7.37
7.76
7.29

EV:EBITDA (Average)

8 Years
5 Years
3 Years

26.47
28.83
27.58

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS 12.71 12.35 10.87 15.23
P/E Ratio 51.56 53.06 60.29 43.03
Revenue 3489 3642 3943 4586
EBITDA 1070 1044 1021 1298
Net Income 510 496 431 607
ROA 8.5 7.7 6.6 8.8
P/B Ratio 6.29 5.58 5.16 4.67
ROE 12.95 11.05 8.65 10.93
FCFF 603 444 205 474
FCFF Yield 2.37 1.75 0.81 1.87
Net Debt -522 -820 -1311 -1835
BVPS 104.26 117.43 127.09 140.37

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 948.40 864.70 9.68% 877.10 791.90 10.76% 821.30 830.70 -1.13% 726.50 715.80 1.49%
Expenses 638.40 565.40 12.91% 627.40 592.40 5.91% 616.70 614.10 0.42% 578.30 552.40 4.69%
EBITDA 310.00 299.30 3.58% 249.70 199.50 25.16% 204.60 216.60 -5.54% 148.20 163.40 -9.30%
EBIDTM 32.69% 34.61% 28.47% 25.19% 24.91% 26.07% 20.40% 22.83%
Other Income 18.40 15.30 20.26% 19.10 28.80 -33.68% 20.40 21.00 -2.86% 17.70 22.90 -22.71%
Interest 10.10 8.50 18.82% 6.70 6.30 6.35% 7.00 8.60 -18.60% 7.40 6.10 21.31%
Depreciation 89.60 95.70 -6.37% 92.30 93.60 -1.39% 93.70 90.90 3.08% 91.70 88.70 3.38%
PBT 228.70 210.40 8.70% 169.80 124.70 36.17% 124.30 130.70 -4.90% 98.80 91.50 7.98%
Tax 54.30 20.60 163.59% 46.70 24.90 87.55% 27.70 29.10 -4.81% 24.90 16.20 53.70%
PAT 174.40 189.80 -8.11% 123.10 99.80 23.35% 96.60 101.60 -4.92% 73.90 75.30 -1.86%
PATM 18.39% 21.95% 14.03% 12.60% 11.76% 12.23% 10.17% 10.52%
EPS 4.33 4.72 -8.26% 3.06 2.48 23.39% 2.40 2.52 -4.76% 1.84 1.87 -1.60%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 1,018.00 916.90 11.03% 943.70 853.50 10.57% 891.00 910.10 -2.10% 789.70 808.10 -2.28%
Expenses 674.40 600.00 12.40% 661.80 622.00 6.40% 650.50 656.00 -0.84% 619.90 596.20 3.98%
EBITDA 343.60 316.90 8.43% 281.90 231.50 21.77% 240.50 254.10 -5.35% 169.80 211.90 -19.87%
EBIDTM 33.75% 34.56% 29.87% 27.12% 26.99% 27.92% 21.50% 26.22%
Other Income 18.90 16.10 17.39% 20.00 29.30 -31.74% 20.80 21.60 -3.70% 18.10 23.60 -23.31%
Interest 15.90 12.90 23.26% 12.40 10.80 14.81% 13.10 13.00 0.77% 11.70 10.50 11.43%
Depreciation 106.10 111.10 -4.50% 108.70 108.10 0.56% 110.90 104.60 6.02% 106.90 102.10 4.70%
PBT 240.50 209.00 15.07% 180.80 138.20 30.82% 137.30 150.70 -8.89% 101.30 122.90 -17.58%
Tax 57.20 20.40 180.39% 49.70 26.70 86.14% 31.20 34.20 -8.77% 25.60 29.50 -13.22%
PAT 183.30 188.60 -2.81% 131.10 111.50 17.58% 106.10 116.50 -8.93% 75.70 93.40 -18.95%
PATM 18.01% 20.57% 13.89% 13.06% 11.91% 12.80% 9.59% 11.56%
EPS 4.55 4.69 -2.99% 3.26 2.77 17.69% 2.64 2.90 -8.97% 1.88 2.32 -18.97%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales - 3,373.30 3,203.10 3,193.50 2,601.40 2,179.40 2,011.90 1,825.60 1,423.10 1,200.90 1,107.00 Net Sales Growth - 5.31% 0.30% 22.76% 19.36% 8.33% 10.20% 28.28% 18.50% 8.48% Cost Of Goods Sold - 17.10 56.60 -42.00 -21.60 526.50 519.40 531.30 381.70 321.80 310.40 Gross Profit - 3,356.20 3,146.50 3,235.50 2,623.00 1,652.90 1,492.50 1,294.30 1,041.40 879.10 796.60 GP Margin - 99.49% 98.23% 101.32% 100.83% 75.84% 74.18% 70.90% 73.18% 73.20% 71.96% Total Expenditure - 2,455.80 2,324.40 2,260.90 1,863.60 1,528.10 1,409.70 1,291.10 1,033.00 816.20 726.60 Power & Fuel Cost - 55.00 54.20 69.20 64.40 57.40 45.80 41.30 34.70 30.40 30.80 % Of Sales - 1.63% 1.69% 2.17% 2.48% 2.63% 2.28% 2.26% 2.44% 2.53% 2.78% Employee Cost - 841.70 761.20 812.20 697.80 641.50 572.20 465.40 376.90 308.60 249.30 % Of Sales - 24.95% 23.76% 25.43% 26.82% 29.43% 28.44% 25.49% 26.48% 25.70% 22.52% Manufacturing Exp. - 1,106.10 1,031.20 1,078.80 913.70 130.00 103.70 85.70 66.70 55.50 29.50 % Of Sales - 32.79% 32.19% 33.78% 35.12% 5.96% 5.15% 4.69% 4.69% 4.62% 2.66% General & Admin Exp. - 373.00 314.80 250.40 168.70 136.10 140.60 146.00 142.40 83.40 64.80 % Of Sales - 11.06% 9.83% 7.84% 6.48% 6.24% 6.99% 8.00% 10.01% 6.94% 5.85% Selling & Distn. Exp. - 19.40 16.20 18.00 11.80 6.10 11.10 7.70 6.10 6.30 4.80 % Of Sales - 0.58% 0.51% 0.56% 0.45% 0.28% 0.55% 0.42% 0.43% 0.52% 0.43% Miscellaneous Exp. - 43.50 90.20 74.30 28.80 30.50 16.90 13.70 24.50 10.20 4.80 % Of Sales - 1.29% 2.82% 2.33% 1.11% 1.40% 0.84% 0.75% 1.72% 0.85% 3.34% EBITDA - 917.50 878.70 932.60 737.80 651.30 602.20 534.50 390.10 384.70 380.40 EBITDA Margin - 27.20% 27.43% 29.20% 28.36% 29.88% 29.93% 29.28% 27.41% 32.03% 34.36% Other Income - 70.50 88.00 72.60 108.40 83.30 96.10 76.20 136.10 93.60 6.30 Interest - 31.20 29.50 45.20 24.10 27.70 34.60 32.30 22.70 17.50 8.40 Depreciation - 367.20 368.80 359.10 309.70 274.50 219.30 164.20 131.40 114.30 97.30 PBT - 589.60 568.40 600.90 512.40 432.40 444.40 414.20 372.10 346.50 281.00 Tax - 153.60 90.80 127.90 87.90 63.70 104.20 83.50 67.00 59.20 40.20 Tax Rate - 24.71% 16.29% 21.28% 18.25% 13.63% 20.21% 20.16% 18.01% 17.09% 14.31% PAT - 468.00 466.50 473.00 393.80 403.70 411.50 330.70 305.10 287.30 240.80 PAT before Minority Interest - 468.00 466.50 473.00 393.80 403.70 411.50 330.70 305.10 287.30 240.80 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 13.87% 14.56% 14.81% 15.14% 18.52% 20.45% 18.11% 21.44% 23.92% 21.75% PAT Growth - 0.32% -1.37% 20.11% -2.45% -1.90% 24.43% 8.39% 6.20% 19.31% EPS - 11.63 11.59 11.75 9.78 10.03 10.22 8.22 7.58 7.14 5.98

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Net Sales - 3,642.40 3,488.60 3,192.90 2,604.20 2,184.30 2,011.90 1,825.60 1,423.10 Net Sales Growth - 4.41% 9.26% 22.61% 19.22% 8.57% 10.20% 28.28% Cost Of Goods Sold - 17.00 56.70 -42.00 -21.60 526.50 519.40 531.30 381.70 Gross Profit - 3,625.40 3,431.90 3,234.90 2,625.80 1,657.80 1,492.50 1,294.30 1,041.40 GP Margin - 99.53% 98.37% 101.32% 100.83% 75.90% 74.18% 70.90% 73.18% Total Expenditure - 2,600.60 2,474.20 2,260.20 1,863.70 1,531.20 1,408.50 1,289.90 1,032.60 Power & Fuel Cost - 69.00 69.70 69.20 64.80 57.40 45.80 41.30 34.70 % Of Sales - 1.89% 2.00% 2.17% 2.49% 2.63% 2.28% 2.26% 2.44% Employee Cost - 983.90 888.70 841.70 718.10 660.20 580.40 472.70 379.60 % Of Sales - 27.01% 25.47% 26.36% 27.57% 30.22% 28.85% 25.89% 26.67% Manufacturing Exp. - 1,184.30 1,082.00 1,078.80 913.70 130.10 103.70 85.70 66.70 % Of Sales - 32.51% 31.02% 33.79% 35.09% 5.96% 5.15% 4.69% 4.69% General & Admin Exp. - 278.00 264.10 219.90 148.50 120.50 131.60 137.40 139.30 % Of Sales - 7.63% 7.57% 6.89% 5.70% 5.52% 6.54% 7.53% 9.79% Selling & Distn. Exp. - 22.70 20.30 18.50 11.70 6.40 11.10 7.70 6.10 % Of Sales - 0.62% 0.58% 0.58% 0.45% 0.29% 0.55% 0.42% 0.43% Miscellaneous Exp. - 45.70 92.70 74.10 28.50 30.10 16.50 13.80 24.50 % Of Sales - 1.25% 2.66% 2.32% 1.09% 1.38% 0.82% 0.76% 1.72% EBITDA - 1,041.80 1,014.40 932.70 740.50 653.10 603.40 535.70 390.50 EBITDA Margin - 28.60% 29.08% 29.21% 28.43% 29.90% 29.99% 29.34% 27.44% Other Income - 71.80 90.60 72.60 108.40 83.30 96.10 76.20 136.10 Interest - 53.10 47.20 45.20 24.10 27.70 34.60 32.30 22.70 Depreciation - 432.60 425.90 366.50 309.70 274.50 219.30 164.20 131.40 PBT - 627.90 631.90 593.60 515.10 434.20 445.60 415.40 372.50 Tax - 163.70 110.80 129.20 88.60 64.30 104.80 83.80 67.10 Tax Rate - 24.81% 17.85% 21.77% 18.29% 13.70% 20.27% 20.17% 18.01% PAT - 496.20 510.00 464.40 395.80 404.90 412.10 331.60 305.40 PAT before Minority Interest - 496.20 510.00 464.40 395.80 404.90 412.10 331.60 305.40 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 13.62% 14.62% 14.54% 15.20% 18.54% 20.48% 18.16% 21.46% PAT Growth - -2.71% 9.82% 17.33% -2.25% -1.75% 24.28% 8.58% EPS - 12.33 12.67 11.54 9.83 10.06 10.24 8.24 7.59

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 4,638.90 4,191.50 3,618.90 3,292.00 2,818.30 2,174.10 1,967.20 1,720.10 1,413.10 1,024.70 Share Capital 402.50 402.00 401.40 400.80 400.00 400.00 200.00 200.00 200.00 200.00 Total Reserves 4,208.60 3,772.10 3,154.70 2,804.20 2,341.40 1,735.20 1,739.20 1,491.90 1,187.90 805.80 Non-Current Liabilities 409.50 494.00 780.40 972.20 840.10 325.20 515.00 612.60 697.70 725.10 Secured Loans 0.00 100.00 489.00 531.50 512.40 0.00 346.60 568.80 689.80 725.20 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 16.70 0.00 0.00 Long Term Provisions 40.40 38.10 41.70 34.40 52.00 40.90 37.40 29.00 19.90 18.10 Current Liabilities 1,328.60 1,098.60 1,157.20 1,231.50 1,130.40 1,540.00 1,128.60 783.30 600.30 534.00 Trade Payables 346.50 254.00 260.40 235.30 239.10 222.80 223.50 203.40 102.50 74.40 Other Current Liabilities 809.10 688.90 749.70 655.90 571.60 955.10 677.60 475.60 379.40 276.40 Short Term Borrowings 102.50 41.70 86.30 258.10 259.90 308.90 190.70 78.10 97.20 165.80 Short Term Provisions 70.50 114.00 60.80 82.20 59.80 53.20 36.80 26.20 21.20 17.40 Total Liabilities 6,377.00 5,784.10 5,556.50 5,495.70 4,788.80 4,039.30 3,610.80 3,116.00 2,711.10 2,283.80 Net Block 2,206.90 2,276.80 2,211.80 2,354.30 2,163.40 1,983.70 1,336.80 1,030.40 810.40 580.20 Gross Block 4,483.40 4,293.50 3,993.60 3,882.50 3,404.40 2,967.40 2,121.20 1,660.70 1,331.90 1,111.40 Accumulated Depreciation 2,276.50 2,016.70 1,781.80 1,528.20 1,241.00 983.70 784.40 630.30 521.50 531.20 Non Current Assets 4,343.10 3,932.30 2,884.10 3,292.10 2,987.80 2,427.90 1,848.20 1,396.70 1,187.00 949.10 Capital Work in Progress 880.10 759.60 126.20 346.40 237.20 234.10 273.70 155.40 174.90 236.80 Non Current Investment 870.10 435.00 116.40 270.60 316.60 74.30 40.30 0.30 0.00 0.00 Long Term Loans & Adv. 173.10 230.30 164.50 150.70 115.10 107.80 121.90 94.90 91.20 71.70 Other Non Current Assets 178.60 189.50 217.10 131.60 155.50 28.00 75.50 115.70 110.50 60.40 Current Assets 2,033.90 1,851.80 2,355.30 2,203.60 1,801.00 1,611.40 1,762.60 1,719.30 1,524.10 1,334.70 Current Investments 597.90 492.60 824.40 763.80 423.30 738.40 716.00 157.70 540.40 276.60 Inventories 150.30 234.00 332.80 179.40 59.60 25.20 43.40 86.00 32.20 37.70 Sundry Debtors 469.40 427.50 484.40 508.20 474.40 398.20 338.70 266.80 198.70 185.20 Cash & Bank 652.50 528.20 509.30 515.10 638.20 280.30 435.40 966.50 527.30 719.90 Other Current Assets 163.80 111.30 140.10 157.00 205.50 169.30 229.10 242.30 225.50 115.30 Short Term Loans & Adv. 45.80 58.20 64.30 80.10 31.60 68.70 3.90 5.90 23.90 25.10 Net Current Assets 705.30 753.20 1,198.10 972.10 670.60 71.40 634.00 936.00 923.80 800.70 Total Assets 6,377.00 5,784.10 5,239.40 5,495.70 4,788.80 4,039.30 3,610.80 3,116.00 2,711.10 2,283.80

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Shareholder's Funds 4,726.70 4,257.60 3,618.00 3,297.60 2,821.40 2,175.80 1,968.40 1,720.40 Share Capital 402.50 402.00 401.40 400.80 400.00 400.00 200.00 200.00 Total Reserves 4,244.90 3,786.60 3,151.20 2,809.30 2,344.40 1,736.90 1,740.40 1,492.20 Non-Current Liabilities 643.40 708.90 955.20 971.70 839.70 325.20 515.00 612.60 Secured Loans 0.00 100.00 489.00 531.50 512.40 0.00 346.60 568.80 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 16.70 Long Term Provisions 43.30 40.70 43.70 34.40 52.00 40.90 37.40 29.00 Current Liabilities 1,396.40 1,144.30 1,188.20 1,228.90 1,133.00 1,539.20 1,128.60 783.60 Trade Payables 352.00 255.50 258.00 232.80 241.60 222.00 223.50 203.50 Other Current Liabilities 845.10 726.80 778.20 655.80 571.60 955.10 677.60 475.70 Short Term Borrowings 119.60 41.70 86.30 258.10 259.90 308.90 190.70 78.10 Short Term Provisions 79.70 120.30 65.70 82.20 59.90 53.20 36.80 26.30 Total Liabilities 6,766.50 6,110.80 5,761.40 5,498.20 4,794.10 4,040.20 3,612.00 3,116.60 Net Block 2,767.40 2,808.90 2,618.80 2,354.30 2,163.40 1,983.70 1,336.80 1,030.40 Gross Block 5,229.30 4,945.80 4,481.40 3,882.50 3,404.40 2,967.40 2,121.20 1,660.70 Accumulated Depreciation 2,461.90 2,136.90 1,862.60 1,528.20 1,241.00 983.70 784.40 630.30 Non Current Assets 4,479.20 4,151.90 3,336.10 3,292.30 2,987.40 2,427.60 1,847.90 1,396.40 Capital Work in Progress 1,266.10 838.10 176.90 346.40 237.20 234.10 273.70 155.40 Non Current Investment 36.20 34.70 94.10 270.30 316.30 74.00 40.00 0.00 Long Term Loans & Adv. 196.40 239.60 181.10 151.20 115.00 107.80 121.90 94.90 Other Non Current Assets 178.80 189.50 217.10 131.60 155.50 28.00 75.50 115.70 Current Assets 2,287.30 1,958.90 2,425.30 2,205.90 1,806.70 1,612.60 1,764.10 1,720.20 Current Investments 610.50 513.20 824.40 763.80 423.30 738.40 716.00 157.70 Inventories 155.50 238.50 332.80 179.40 59.60 25.20 43.40 86.00 Sundry Debtors 526.80 441.50 529.30 507.70 475.70 398.20 338.70 266.80 Cash & Bank 786.90 563.50 531.70 517.90 642.60 281.50 436.90 967.40 Other Current Assets 207.60 106.40 132.40 157.00 205.50 169.30 229.10 242.30 Short Term Loans & Adv. 104.20 95.80 74.70 80.10 31.60 68.70 3.90 5.90 Net Current Assets 890.90 814.60 1,237.10 977.00 673.70 73.40 635.50 936.60 Total Assets 6,766.50 6,110.80 5,761.40 5,498.20 4,794.10 4,040.20 3,612.00 3,116.60

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 1,113.80 913.40 838.40 582.20 698.00 677.40 629.80 445.60 398.10 308.10 PBT 621.60 557.30 600.90 481.70 467.40 515.70 330.70 305.10 287.30 240.80 Adjustment 366.10 286.30 375.30 381.30 278.60 223.20 212.50 248.10 148.40 132.90 Changes in Working Capital 227.60 168.20 -4.10 -176.60 34.80 44.90 182.30 -26.80 36.90 -25.50 Cash after chg. in Working capital 1,215.30 1,011.80 972.10 686.40 780.80 783.80 725.50 526.40 472.60 348.20 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -101.50 -98.40 -133.70 -104.20 -82.80 -106.40 -95.70 -80.80 -74.50 -40.10 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -810.40 -383.50 -688.20 -611.50 -628.10 -428.40 -646.50 -349.60 -469.10 -751.20 Net Fixed Assets -310.40 -933.30 109.10 -587.30 -440.10 -806.60 -578.80 -309.30 -158.60 -305.10 Net Investments -540.40 13.20 93.60 -294.50 72.80 -56.40 -598.30 382.40 -263.80 -130.60 Others 40.40 536.60 -890.90 270.30 -260.80 434.60 530.60 -422.70 -46.70 -315.50 Cash from Financing Activity -136.50 -536.30 -340.20 -31.30 58.00 -225.50 -72.40 -78.70 -81.20 716.10 Net Cash Inflow / Outflow 166.90 -6.40 -190.00 -60.60 127.90 23.50 -89.10 17.30 -152.20 273.00 Opening Cash & Equivalents 66.60 72.10 259.00 318.90 191.80 163.70 251.80 234.50 387.30 115.70 Closing Cash & Equivalent 233.50 66.60 72.10 259.00 318.90 191.80 163.70 251.80 234.50 387.30

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Cash From Operating Activity 1,167.60 1,042.10 823.50 580.60 701.20 677.10 630.40 446.20 PBT 659.80 620.80 593.60 484.40 469.30 516.90 331.60 305.40 Adjustment 470.90 390.40 384.90 381.70 278.80 223.20 212.80 248.20 Changes in Working Capital 152.10 156.00 -18.20 -179.70 36.70 44.10 182.10 -26.60 Cash after chg. in Working capital 1,282.80 1,167.20 960.30 686.40 784.80 784.20 726.50 527.00 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -115.20 -125.10 -136.80 -105.80 -83.60 -107.10 -96.10 -80.80 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -744.70 -495.60 -656.40 -611.50 -628.10 -428.40 -646.50 -349.30 Net Fixed Assets -310.40 -933.30 109.10 -587.30 -440.10 -806.60 -578.80 Net Investments -540.40 13.20 93.60 -294.50 72.80 -56.40 -598.30 Others 106.10 424.50 -859.10 270.30 -260.80 434.60 530.60 Cash from Financing Activity -141.80 -551.40 -342.50 -31.30 58.00 -225.50 -72.40 -78.70 Net Cash Inflow / Outflow 281.10 -4.90 -175.40 -62.20 131.10 23.20 -88.50 18.20 Opening Cash & Equivalents 85.70 89.50 261.80 323.30 193.00 165.20 252.70 234.50 Closing Cash & Equivalent 367.10 85.70 89.50 261.80 323.30 193.00 165.20 252.70

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 114.56 103.83 88.59 79.97 68.53 53.38 48.48 42.30 34.70 25.14 ROA 7.70% 8.08% 8.40% 7.66% 9.15% 10.76% 9.83% 10.47% 11.50% 13.00% ROE 10.65% 12.07% 13.99% 13.24% 16.56% 20.20% 18.21% 19.81% 24.00% 26.19% ROCE 14.39% 13.76% 15.61% 13.19% 15.35% 19.57% 16.94% 16.70% 17.60% 19.85% Fixed Asset Turnover 0.77 0.77 0.81 0.71 0.68 0.79 0.97 0.95 0.98 1.08 Receivable days 48.33 51.89 56.66 68.93 73.07 66.84 60.53 59.70 58.34 60.19 Inventory Days 20.71 32.26 29.24 16.77 7.10 6.22 12.94 15.16 10.62 12.55 Payable days 6408.85 1658.62 -2153.93 -4008.24 160.11 54.64 59.61 54.99 38.31 36.00 Cash Conversion Cycle -6339.81 -1574.47 2239.83 4093.94 -79.94 18.42 13.85 19.87 30.65 36.74 Total Debt/Equity 0.02 0.03 0.16 0.25 0.28 0.32 0.41 0.47 0.58 0.89 Interest Cover 20.92 19.89 14.29 20.99 17.87 15.90 13.82 17.39 20.80 34.45

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Book Value (Rs.) 115.46 104.19 88.51 80.09 68.61 53.42 48.51 42.30 ROA 7.71% 8.59% 8.25% 7.69% 9.17% 10.77% 9.86% 9.80% ROE 11.23% 13.18% 13.73% 13.29% 16.59% 20.21% 18.26% 18.05% ROCE 15.42% 15.55% 15.43% 13.24% 15.40% 19.60% 16.98% 15.76% Fixed Asset Turnover 0.72 0.74 0.76 0.71 0.69 0.79 0.97 0.86 Receivable days 48.33 50.73 59.21 68.92 73.02 66.84 60.53 68.43 Inventory Days 19.66 29.85 29.24 16.75 7.09 6.22 12.94 22.06 Payable days 6521.69 1652.80 -2132.64 -4008.24 160.70 54.25 59.30 72.96 Cash Conversion Cycle -6453.70 -1572.22 2221.09 4093.91 -80.60 18.82 14.17 17.52 Total Debt/Equity 0.03 0.03 0.16 0.25 0.28 0.32 0.41 0.47 Interest Cover 13.43 14.15 14.13 21.10 17.94 15.94 13.86 17.41

Top Investors:

icici prudential innovation fund

mirae asset equity savings fund

government of singapore

government pension fund global

nippon life india trustee ltd-a/c nippon india fle

uti nifty midsmallcap 400 momentum quality 100 ind

lici new endowment plus-growth fund

dsp nifty healthcare etf

Annual Reports:

News Update:

USFDA conducts GCP compliance inspection of Syngene International’s Bengaluru facility
14th Jun 2025, 10:38 AM

The inspection concluded successfully, with the facility found to be in compliance with the required regulations
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback